Publication:
Anti-mmu-mir-721 as a therapeutic target for immune checkpoint inhibitor-associated myocarditis

dc.contributor.authorOrtega Sollero, E
dc.contributor.authorJimenez-Alejandre, R
dc.contributor.authorOrtego-Molto, R
dc.contributor.authorSanchez-Diaz, R
dc.contributor.authorMartin, P
dc.date.accessioned2026-03-20T11:41:29Z
dc.date.available2026-03-20T11:41:29Z
dc.date.issued2025-08-01
dc.description.abstract
dc.description.peerreviewed
dc.identifier.doi10.1093/eurheartjsupp/suaf083.237
dc.identifier.issn1520-765X
dc.identifier.issn1554-2815
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27341
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.publisherversion10.1093/eurheartjsupp/suaf083.237
dc.repisalud.institucionCNIC
dc.repisalud.orgCNICCNIC::Grupos de investigación::Moléculas Reguladoras de los Procesos Inflamatorios
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleAnti-mmu-mir-721 as a therapeutic target for immune checkpoint inhibitor-associated myocarditis
dc.typeconference presentation
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Anti-mmu-mir-721 as a therapeutic target for immune_Eur Heart J Supplements_2025.pdf
Size:
380.98 KB
Format:
Adobe Portable Document Format